Novartis India is currently trading at Rs. 662.85, up by 2.55 points or 0.39% from its previous closing of Rs. 660.30 on the BSE.
The scrip opened at Rs. 664.95 and has touched a high and low of Rs. 669.00 and Rs. 656.30 respectively. So far 10339 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 760.00 on 09-Sep-2014 and a 52 week low of Rs. 394.50 on 14-Feb-2014.
Last one week high and low of the scrip stood at Rs. 688.50 and Rs. 653.30 respectively. The current market cap of the company is Rs. 2121.72 crore.
The promoters holding in the company stood at 75.00% while Institutions and Non-Institutions held 3.72% and 21.28% respectively.
Novartis is all set to offload its Over-The-Counter Division (OTC Division) of Indian arm to GlaxoSmithKline Consumer, Indian entity of UK-based GlaxoSmithKline, under the agreement for business transferring between Novartis and GlaxoSmithKline signed last year.
On January 13, 2015, the company’s board approved the transfer of the OTC Division as a going concern by way of a ‘slump sale’ to GSK CPL (affiliate of GSK) for a consideration of Rs 109.7 crore, on or before 22 October 2015, as well as closing of the global Joint Venture transaction between Novartis AG and GS.
As part of its global portfolio transformation, Novartis AG, agreed with GlaxoSmithKline plc, UK on 22 April 2014 to create a global consumer healthcare joint venture. In the joint venture, GSK will own 63.5% stake while Novartis would own the remaining 36.5% holding.
| Company Name | CMP |
|---|---|
| Redington | 194.65 |
| Adani Enterprises | 2812.20 |
| Amrapali Industries | 17.79 |
| Rashi Peripheral | 367.70 |
| Compuage Infocom | 2.71 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
